Carregant...
Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
Mesalazine is a key drug used for remission induction and maintenance therapy in inflammatory bowel disease (IBD). We sometimes encounter patients who develop allergic reactions to the drug and inevitably discontinue treatment. Of 692 patients who received mesalazine for IBD between 2014 and March 2...
Guardat en:
| Publicat a: | Sci Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7747557/ https://ncbi.nlm.nih.gov/pubmed/33335169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-79207-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|